Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.99
-0.24 (-2.92%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Actuate Therapeutics Employees
Actuate Therapeutics had 10 employees as of December 31, 2024. The number of employees increased by 5 or 100.00% compared to the previous year.
Employees
10
Change (1Y)
5
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$2,728,533
Market Cap
156.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10 | 5 | 100.00% |
| Dec 31, 2023 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
ACTU News
- 3 days ago - Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025 - GlobeNewsWire
- 2 months ago - Actuate Therapeutics to Participate in Upcoming Investor Conferences in February - GlobeNewsWire
- 4 months ago - Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer - GlobeNewsWire
- 6 months ago - Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development - GlobeNewsWire
- 7 months ago - Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma - GlobeNewsWire
- 8 months ago - Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 8 months ago - U.S. IPO Weekly Recap: WeRide Reschedules While 6 New Filers Join The Pipeline - Seeking Alpha
- 8 months ago - Actuate Therapeutics Announces Closing of Initial Public Offering - GlobeNewsWire